MedPath

Optimized antibiotic treatment in Korean patients with Clostroides difficile infectio

Not Applicable
Recruiting
Conditions
Certain infectious and parasitic diseases
Registration Number
KCT0006008
Lead Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
438
Inclusion Criteria

Inclusion criteria
Adults aged 19 to 85, patients with clinical symptoms, laboratory tests confirmed CDI.
Patients not receiving CDI treatment in the past 10 days
Patients of childbearing potential who are not pregnant prior to participation in the clinical trial

Exclusion Criteria

Exclusion criteria
Patients who have experienced at least one CDI within 3 months prior to participation in the clinical trial
Patients taking to be treated with prohibited medications
Pregnant or lactating women
Patients with ulcerative colitis or Crohn's disease
Patients undergone colon resection
Patients has a current diagnosis of toxic megacolon
Patient has hypersensitivity to metronidazole
Patients has hypersensitivity to vancomycin

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cure Rate at End of Therapy
Secondary Outcome Measures
NameTimeMethod
Recurrence;Global Cure
© Copyright 2025. All Rights Reserved by MedPath